...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM

This month I believe we are heading for the AGM

Based on what I am aware of it looks like it will be another non event with no news and many false promises by DM.

What a pity. I sure hope for once I am wrong but I doubt it.

Toinv

Share
New Message
Please login to post a reply